Citius Initiates Mino-Lok™ Phase 3 Trial
Go back to Citius Initiates Mino-Lok™ Phase 3 Trial| (NASDAQ: CTXR) | Delayed: 0.73 -0.03 (3.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.76 | 52 Week High | $2.50 | |||
| Open | $0.77 | 52 Week Low | $0.40 | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $0.00 | |||
| Volume | 435,163 | |||||
| Medspas of America, Inc. New (NASDAQ: MEDP) | Delayed: 581.95 -15.03 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $596.98 | 52 Week High | $35.58 | |||
| Open | $600.40 | 52 Week Low | $26.54 | |||
| Day High | $602.50 | P/E | N/A | |||
| Day Low | $581.29 | EPS | $0.00 | |||
| Volume | 151,061 | |||||
